InvestorsHub Logo
Followers 0
Posts 484
Boards Moderated 0
Alias Born 10/10/2014

Re: None

Thursday, 08/31/2017 3:35:44 PM

Thursday, August 31, 2017 3:35:44 PM

Post# of 2099
Assuming positive DSMC review (which I think is likely - > 50% chance), what is the next significant milestone? I am thinking it will be either the Ovarian phase 3 first patient announcement or the announcement that VB-111 is being evaluated in combination with an anti-PD-L1 checkpoint inhibitor partner.

Anything else? Facilities is good news, but perhaps not as significant? Or is it?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News